Strata Critical Medical, Inc.
SRTAHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeStrata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. Valued at $469.8M, SRTA is a small-cap name in its sector. It operates in two segments, Logistics and Clinical.
Market Cap
$469.8M
Beta
2.26
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-0.28
EPS (Fwd)
—
ROE
-9.2%
ROA
-1.9%
Cash
$22.8M
Total Debt
$4.3M
Free CF
-$20.1M
52W Change
33.3%
Annual Financials
Cash vs Debt
Where SRTA stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, SRTA finished 5.27% above its 150-day moving average ($5.12) and 5.89% above its 200-day moving average ($5.09). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SRTA overbought or oversold?
At the September 3, 2026 close, SRTA's RSI(14) was 37.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $22.8M in cash comfortably exceeding the $4.3M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow is running at -$20.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -9.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $146.1M (2022) to $197.1M (2025), reflecting a 35% increase over the period.
A beta of 2.26 means SRTA is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. With cash comfortably exceeding debt, SRTA has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing SRTA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.